Amarin (AMRN - Get Report) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. This stock is trading up 10.1% at $8.83 in recent trading.
Today's Range: $7.77-$952-Week Range: $5.99-$19.87 Volume: 7.7 million Three-Month Average Volume: 3.05 million >>Health Care Stocks Bought and Sold by Hedge Funds From a technical perspective, AMRN is spiking big today and moving back above its 50-day moving average of $8.11 with monster volume. This move puts AMRN within range of triggering some near-term breakouts. Those breakouts will hit once $9.11 to $9.50 are taken out with volume. A sustained high-volume move and close above those levels will signal that this stock wants to trend higher. Look for volume on that move that's near or well above 3,053,130 shares. If we get that action soon, look for AMRN to challenge the mid-$11s. Follow @stockpickr
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts